Gene expression signature in endemic osteoarthritis by microarray analysis

Xi Wang1, Yujie Ning2, Feng Zhang3

  • 1School of Public Health, Xi'an Jiaotong University Health Science Center, Key Laboratory of Trace Elements and Endemic Diseases, National Health and Family Planning Commission, No. 76 Yanta West Road, Xi'an 710061, China. wx231115210@stu.xjtu.edu.cn.

Insights

Researchers identified a 20-gene signature in blood to detect Kashin-Beck Disease (KBD) early. This discovery offers a promising blood test for diagnosing KBD, enabling timely treatment.

Area of Science:

  • Biochemistry
  • Genetics
  • Osteology

Background:

  • Kashin-Beck Disease (KBD) is an endemic osteochondropathy with unknown pathogenesis.
  • Current KBD diagnosis is only effective in advanced stages, hindering early intervention.
  • There is a critical need for early diagnostic methods for KBD.

Purpose of the Study:

  • To identify a blood-based gene expression signature for early KBD detection.
  • To develop a non-invasive diagnostic tool for Kashin-Beck Disease.
  • To improve KBD patient outcomes through early diagnosis and treatment.

Main Methods:

  • Comparative analysis of gene expression profiles from cartilage and peripheral blood mononuclear cells (PBMCs).
  • Microarray analysis of target genes in 100 KBD patients and 100 healthy controls.
  • Validation of a gene signature using mRMR and SVM algorithms on training and test sets.

Main Results:

  • Fifty unique genes were found to be differentially expressed between KBD patients and controls.
  • A 20-gene signature was identified with 90% accuracy, 85% sensitivity, and 95% specificity.
  • The 20-gene signature accurately distinguishes KBD patients from healthy individuals using peripheral blood.

Conclusions:

  • A 20-gene signature in peripheral blood can accurately detect Kashin-Beck Disease.
  • This finding supports the development of blood-based genetic biomarkers for KBD diagnosis.
  • Early detection of KBD via a blood test could significantly improve patient prognosis.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.8K
DNA Microarrays02:34

DNA Microarrays

Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
23.1K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
14.1K